Basit öğe kaydını göster

dc.contributor.authorDEMİR, Semra
dc.contributor.authorGELİNCİK, Aslı
dc.contributor.authorKÖSE, Murat
dc.contributor.authorBuyukozturk, Suna
dc.contributor.authorColakoglu, Bahauddin
dc.contributor.authorCan, Ali
dc.contributor.authorKarabacak, Deniz Eyice
dc.contributor.authorTuzer, Can
dc.contributor.authorAlibeyoglu, Alpay
dc.date.accessioned2022-02-18T09:00:31Z
dc.date.available2022-02-18T09:00:31Z
dc.date.issued2021
dc.identifier.citationCan A., Karabacak D. E. , Tuzer C., Alibeyoglu A., KÖSE M., DEMİR S., Buyukozturk S., Colakoglu B., GELİNCİK A., "Atopy and Allergic Diseases Have No Impact on the Severity of COVID-19", ASTIM ALLERJI IMMUNOLOJI, cilt.19, sa.3, ss.174-182, 2021
dc.identifier.othervv_1032021
dc.identifier.otherav_104ac5ef-8617-47a4-9415-c64cecfb675a
dc.identifier.urihttp://hdl.handle.net/20.500.12627/176310
dc.identifier.urihttps://avesis.istanbul.edu.tr/api/publication/104ac5ef-8617-47a4-9415-c64cecfb675a/file
dc.identifier.urihttps://doi.org/10.21911/aai.676
dc.description.abstractObjective: The clinical features of COVID-19 range from asymptomatic disease to severe pneumonia or even death. Therefore, many researchers have investigated the factors that could affect the severity of COVID-19. We aimed to assess the impact of aero-allergen sensitization and allergic diseases on the severity of COVID-19.
dc.language.isoeng
dc.subjectHealth Sciences
dc.subjectImmunology and Allergy
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectALERJİ
dc.titleAtopy and Allergic Diseases Have No Impact on the Severity of COVID-19
dc.typeMakale
dc.relation.journalASTIM ALLERJI IMMUNOLOJI
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume19
dc.identifier.issue3
dc.identifier.startpage174
dc.identifier.endpage182
dc.contributor.firstauthorID3052314


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster